Premium Nahrungsergänzungsmittel | artgerecht

Ciclopirox: Antifungal for Skin and Nail Infections

Ciclopirox is a synthetic antifungal agent used to treat fungal infections of the skin and nails. It inhibits fungal growth and is available as creams, nail lacquers, and shampoos.

Regular tips about health Regular tips about health

Things worth knowing about "Ciclopirox"

Ciclopirox is a synthetic antifungal agent used to treat fungal infections of the skin and nails. It inhibits fungal growth and is available as creams, nail lacquers, and shampoos.

What is Ciclopirox?

Ciclopirox is a synthetic broad-spectrum antifungal agent used to treat fungal infections affecting the skin, nails, and scalp. It belongs to the hydroxypyridone class of antifungals and is available in several formulations, including creams, gels, solutions, nail lacquers, and shampoos. Ciclopirox is both fungicidal (kills fungi) and fungistatic (inhibits fungal growth) and also exhibits antibacterial and anti-inflammatory properties, making it a versatile topical agent.

Indications and Uses

Ciclopirox is indicated for a wide range of fungal infections, including:

Onychomycosis: Fungal infection of the finger- and toenails, commonly caused by dermatophytes or yeasts
Tinea pedis: Athlete's foot, a common infection affecting the skin between the toes and on the soles
Tinea corporis / Tinea cruris: Ringworm of the body or groin area
Pityriasis versicolor: A yeast infection causing discoloration of the skin
Seborrhoeic dermatitis / Dandruff: As a shampoo for fungal-associated scalp scaling
Cutaneous candidiasis: Infections caused by the yeast Candida, often in skin folds

Mechanism of Action

Ciclopirox works through a unique mechanism that distinguishes it from most other antifungal agents. It acts by chelating divalent and trivalent metal cations such as iron (Fe³⁺) and aluminium (Al³⁺). These metal ions are essential cofactors for numerous vital fungal enzymes. By binding and sequestering these ions, ciclopirox disrupts multiple critical cellular processes in fungi, including:

The mitochondrial electron transport chain, impairing energy production
DNA synthesis and cell division
Peroxidase and catalase enzymes that regulate oxidative stress within the fungal cell

This multi-target mechanism significantly reduces the risk of resistance development compared to single-target antifungals such as azoles. Additionally, ciclopirox inhibits the synthesis of prostaglandins and leukotrienes, which contributes to its anti-inflammatory effect.

Formulations and Dosage

Ciclopirox is available in several formulations suited to different infection types and locations:

Cream / Gel (1%): For skin fungal infections. Typically applied once or twice daily to the affected area.
Nail lacquer (8%): Specifically for the treatment of onychomycosis. Applied daily to the affected nail; treatment usually lasts 6 months for fingernails and up to 12 months for toenails.
Shampoo (1%): For dandruff and seborrhoeic dermatitis of the scalp. Applied twice weekly.
Solution / Nail tincture: As an alternative to the lacquer for nail infections.

The exact dosage and duration of treatment should always follow medical guidance.

Side Effects

Ciclopirox is generally well tolerated, as systemic absorption through the skin is minimal. Possible local side effects include:

Burning, itching, or redness at the site of application
Skin irritation or contact dermatitis (rare)
Nail discoloration or changes when using the nail lacquer
Mild scalp irritation or, rarely, hair loss with shampoo use

Systemic side effects are very uncommon due to the negligible absorption of the drug through intact skin.

Contraindications and Interactions

Ciclopirox should not be used in cases of:

Known hypersensitivity to ciclopirox or any of the excipients in the formulation
Application to the eyes or mucous membranes (unless a specifically approved formulation is used)

During pregnancy and breastfeeding, ciclopirox should only be used after medical consultation, as data is limited. No clinically relevant drug interactions have been identified due to the minimal systemic uptake of the substance.

References

Gupta AK, Foley KA. - Ciclopirox (ciclopirox olamine) for the treatment of superficial fungal infections. - Skin Therapy Letter, 2013.
Faergemann J, Baran R. - Epidemiology, clinical presentation and diagnosis of onychomycosis. - British Journal of Dermatology, 2003; 149 (Suppl 65): 1-4.
European Medicines Agency (EMA) - Assessment reports and product information for ciclopirox-containing medicinal products - www.ema.europa.eu.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.